Herceptin

December 4, 2017December 4, 2017

FDA Approves Ogivri, Biosimilar to Herceptin, to Treat HER2+ Breast Cancer

News

HER2-positive breast cancer patients in the U.S. will have the possibility of being treated with a biosimilar to Herceptin (trastuzumab), following the approval of Ogivri (trastuzumab-dkst) as a more affordable ... Read more

December 8, 2016

Heart Medication Prevents Cardiac Damage Caused by Some Breast Cancer Treatments, Study Finds

News

Heart medication can be prescribed for patients with early-stage breast cancer undergoing chemotherapy with treatments like Herceptin (trastuzumab) to prevent cardiac damage and failure associated with this treatment, according to the ... Read more

November 1, 2016November 1, 2016

Herceptin Seen as Effective and Cost-Effective for ‘Worst-Case’ Early Breast Cancers in Study

News

Depending on the disease characteristics and age of a women with early stage but aggressive breast cancer, the cost-effectiveness of Herceptin (trastuzumab) may vary widely, according to a recent study ... Read more

August 23, 2016August 23, 2016

Kadcycla Effective in Advanced Breast Cancer Patients Already Given Perjeta

News

Kadcyla (ado-trastuzumab emtansine, or T-DM1) may benefit HER2-positive metastatic breast cancer patients whose disease continues to progress despite prior treatment with Herceptin (trastuzumab) and Perjeta (pertuzumab), according to the results ... Read more

August 1, 2016August 1, 2016

Number of HER2-positive Breast Cancers Double Under New Testing Guidelines

News

The American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) changed the guidelines that determine which breast cancers are considered HER2-positive in 2013. According to a recent study from the Mayo ... Read more

June 7, 2016June 8, 2016

All About ER Positive, HER2 Negative Breast Cancer

News

About one in eight women in the United States will develop breast cancer, according to commonly used statistics. But other reports indicate that breast cancer rates are on the decline, likely ... Read more

March 31, 2016March 31, 2016

MD Anderson Researchers Develop Neo-Bioscore, a More Refined Breast Cancer Staging System

News

Researchers at the University of Texas MD Anderson Cancer Center have developed a novel breast cancer staging system called Neo-Bioscore which includes HER2 status of the tumor. This approach is built on ... Read more

March 2, 2016March 2, 2016

HER2-Positive Breast Cancer Shows Strong Immune Response to Single Dose of Trastuzumab

News

Case Western University researchers found that a single dose of the anticancer drug trastuzumab induced a strong immune response in HER2-positive breast cancer tumors. Such results confirm previous research suggesting that intrinsic ... Read more

June 7, 2015October 18, 2016

Genentech Discloses Promising Data on Perjeta in Neoadjuvant Treatment For Specific Breast Cancer Patients

News

Genentech, a member of the Roche Group, recently announced encouraging results on its Phase II NeoSphere trial evaluating Perjeta (pertuzumab) as a neoadjuvant (pre-surgery) treatment in specific early breast cancer ... Read more

January 5, 2015January 5, 2015

Genentech Updates Results From Phase III MARIANNE Trial In Advanced HER2-Positive Breast Cancer Patients

News

Genentech, a member of the Roche Group, recently announced the results from their Phase III MARIANNE study. MARIANNE is an international, multicenter, randomized, three-arm study comprising 1,095 patients with advanced HER2-positive ... Read more